切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Epac - AdipoR1 - Insulin and Insulin-like Receptors - Neuraminidases (NA)

10 件产品

每页
清除全部
  1. 8-CPT-2Me-cAMP, sodium salt
    B6816 8-CPT-2Me-cAMP, sodium salt
    Target: Epac
    Summary: EPAC活化剂
      <50.78 mg/mL
  2. Oseltamivir phosphate
    B1803 Oseltamivir phosphate
     1 Citation
    中文名: 磷酸奥司他韦
    Target: Neuraminidases (NA)
    Summary: 有效的选择性神经氨酸酶抑制剂
      ≥20.3 mg/mL
      ≥110 mg/mL
  3. AdipoRon
    B1879 AdipoRon
    Target: AdipoR1|AdipoR2
    Summary: AdipoR1/2激动剂
      ≥21.45 mg/mL
      insoluble in H2O
  4. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  5. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  6. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  7. X-NeuNAc
    A3944 X-NeuNAc
    Target: Neuraminidases (NA)
    Summary: 神经氨酸酶活性显色试验的底物
      ≥28 mg/mL
      ≥19.9 mg/mL
  8. Oseltamivir acid
    A3689 Oseltamivir acid
     1 Citation
    中文名: 奥斯他伟酸,奥司他韦羧酸,奥司他韦酸,奥塞米韦酸
    Target: Neuraminidases (NA)
    Summary: 流感神经氨酸酶抑制剂
      ≥14.2 mg/mL
      ≥46.1 mg/mL
  9. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  10. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O

10 件产品

每页